Fasting conditions in clinical oncology trials and drug labelling Reply

被引：0
|
作者：
Lubberman, Floor J. E. [1 ]
Burger, David [1 ]
van Erp, Nielka P. [1 ]
机构：
[1] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, NL-6500 HB Nijmegen, Netherlands
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(17)30599-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E507 / E507
页数：1
相关论文
共 50 条
  • [1] Fasting conditions in clinical oncology trials and drug labelling
    Yu, Guo
    Li, Guo-Fu
    Wang, Da-Xin
    Wang, Jingcheng
    Zhou, Hong-Hao
    LANCET ONCOLOGY, 2017, 18 (09): : E506 - E506
  • [2] Clinical Trials in Oncology and Defining Benefit Reply
    Goldberg, Richard M.
    ONCOLOGIST, 2018, 23 (01): : 136 - 136
  • [3] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Lauren A. Marcath
    Taylor D. Coe
    Emily K. Hoylman
    Bruce G. Redman
    Daniel L. Hertz
    BMC Cancer, 18
  • [4] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
  • [5] A Database of Drug Repurposing Clinical Trials in Oncology
    Pantziarka, Pan
    Vandeborne, Liese
    Bouche, Gauthier
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Adverse event development in clinical oncology trials reply
    Thanarajasingam, Gita
    Sloan, Jeff A.
    Grothey, Axel
    LANCET ONCOLOGY, 2016, 17 (07): : E264 - E265
  • [7] Navigating Oncology Clinical Trials: From Drug Development to
    Bourgeois, John
    Goodman, Monica S.
    Braga, Catherine
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2025, 29 (01) : 91 - 95
  • [8] Inappropriate drug labelling - Reply
    McKenna, J
    ANAESTHESIA, 2002, 57 (07) : 730 - 730
  • [9] Reply to 'Fasting in oncology: a word of caution'
    Nencioni, Alessio
    Caffa, Irene
    Cortellino, Salvatore
    Longo, Valter D.
    NATURE REVIEWS CANCER, 2019, 19 (03) : 178 - 178
  • [10] Reply to ‘Fasting in oncology: a word of caution’
    Alessio Nencioni
    Irene Caffa
    Salvatore Cortellino
    Valter D. Longo
    Nature Reviews Cancer, 2019, 19 : 178 - 178
12345